Haryana Has No Report On Coronil Efficacy: RTI Reply

Gurugram : The Haryana’s AYUSH Department, which purchased ₹2.72 crore-worth of Ramdev’s Ayurvedic COVID-19 medicine ‘Coronil’ in May this year, is not in possession of any test reports to establish its efficacy, an RTI reply has revealed.

The department also does not have a record of those who have recovered from the use of the ‘medicine’.

The proposal for the purchase of Coronil was referred by the office of Chief Minister Manohar Lal as per a letter by Haryana Medical Services Corporation Limited, the RTI reply revealed.

Due to paucity of funds with the AYUSH Department, the drug was bought with funds from the Haryana Corona Relief Fund.

The set of documents shared by the department, in reply to the RTI application by Panipat-based activist P.P. Kapoor, revealed that the technical panel of the AYUSH Department met on May 18 and approved the purchase saying the composition and strength of Coronil was as per the recommendations for immunity boosting and “maybe finalised and it may also be suitable for Corona patients”.

The State had 83,161 active cases on the said date and the panel approved to buy one lakh Coronil kits as mentioned in the quote given by Divya Pharmacy. Some of the ingredients of the tablet includes Giloy, Ashwagandha, Tulsi, Mulethi, Marich, and Choti Pipal.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states